Inhibitors | Comment | Organism | Structure |
---|---|---|---|
3-(1-benzyl-2,5-dimethylpyrrol-3-yl)-3-(4-fluorophenyl)-3H-isobenzofuran-1-one | 18% inhibition at 0.033 mM | Homo sapiens | |
3-(2,5-dimethyl-1-phenylpyrrol-3-yl)-3-(4-fluorophenyl)-3H-isobenzofuran-1-one | 40% inhibition at 0.033 mM | Homo sapiens | |
3-(2,5-dimethylpyrrol-3-yl)-3-(4-fluorophenyl)-3H-isobenzofuran-1-one | 35% inhibition at 0.033 mM | Homo sapiens | |
3-(4-fluorophenyl)-3-(1,2,5-trimethylpyrrol-3-yl)-3H-isobenzofuran-1-one | 36% inhibition at 0.033 mM | Homo sapiens | |
3-(4-fluorophenyl)-3-[1-(3-hydroxyphenyl)-2,5-dimethylpyrrol-3-yl]-3H-isobenzofuran-1-one | 30% inhibition at 0.033 mM | Homo sapiens | |
3-(4-fluorophenyl)-3-[1-(4-hydroxyphenyl)-2,5-dimethylpyrrol-3-yl]-3H-isobenzofuran-1-one | 60% inhibition at 0.033 mM | Homo sapiens | |
3-pyrrol-3-yl-3H-isobenzofuran-1-one | synthesis and inhibitory potency of derivatives, overview | Homo sapiens | |
3-[1-(3,4-dihydroxyphenyl)-2,5-dimethylpyrrol-3-yl]-3-(4-fluorophenyl)-3H-isobenzofuran-1-one | 20% inhibition at 0.033 mM | Homo sapiens | |
3-[1-(4-aminophenyl)-2,5-dimethylpyrrol-3-yl]-3-(4-fluorophenyl)-3H-isobenzofuran-1-one | 55% inhibition at 0.033 mM | Homo sapiens | |
3-[2,5-dimethyl-1-(4-methylaminophenyl)pyrrol-3-yl]-3-(4-fluorophenyl)-3H-isobenzofuran-1-one | 36% inhibition at 0.033 mM | Homo sapiens | |
4-(2,4-dioxothiazolidin-5-ylidenemethyl)-N-(4-[1-(4-fluorophenyl)-3-one-1H-isobenzofuran-1-yl]-2,5-dimethyl-1-phenylpyrrol-3-ylmethyl)benzamide | - |
Homo sapiens | |
4-(3-[1-(4-fluorophenyl)-3-oxo-1,3-dihydroisobenzofuran-1-yl]-2,5-dimethylpyrrol-1-yl)benzamide | 42% inhibition at 0.033 mM | Homo sapiens | |
4-(3-[1-(4-fluorophenyl)-3-oxo-1,3-dihydroisobenzofuran-1-yl]-2,5-dimethylpyrrol-1-yl)benzoic acid | 51% inhibition at 0.033 mM | Homo sapiens | |
5-(4-[3-(1-[4-fluorophenyl]-3-oxo-1,3-dihydroisobenzofuran-1-yl)-2,5-dimethyl-pyrrol-1-yl]benzylidene)thiazolidine-2,4-dione | 76% inhibition at 0.033 mM | Homo sapiens | |
arachidonyltrifluoromethyl ketone | - |
Homo sapiens | |
additional information | structure-activity relationship, overview | Homo sapiens | |
N-(4-[3-(1-(4-fluorophenyl)3-oxo-1,3-dihydroisobenzofuran-1-yl)-2,5-dimethylpyrrol-1-yl]phenyl)acetamide | 35% inhibition at 0.033 mM | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytosol | - |
Homo sapiens | 5829 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
blood platelet | - |
Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
cPLA2alpha | - |
Homo sapiens |
cytosolic phospholipase A2alpha | - |
Homo sapiens |